1. Home
  2. BOKF vs PTGX Comparison

BOKF vs PTGX Comparison

Compare BOKF & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BOK Financial Corporation

BOKF

BOK Financial Corporation

SELL

Current Price

$124.50

Market Cap

8.0B

Sector

Finance

ML Signal

SELL

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

SELL

Current Price

$137.53

Market Cap

9.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BOKF
PTGX
Founded
1910
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
9.3B
IPO Year
2007
2016

Fundamental Metrics

Financial Performance
Metric
BOKF
PTGX
Price
$124.50
$137.53
Analyst Decision
Hold
Strong Buy
Analyst Count
11
14
Target Price
$146.67
★ $178.21
AVG Volume (30 Days)
233.9K
★ 753.5K
Earning Date
10-19-2026
11-05-2026
Dividend Yield
★ 2.05%
N/A
EPS Growth
★ 12.65
N/A
EPS
★ 5.49
2.35
Revenue
N/A
N/A
Revenue This Year
$4.28
$1,077.07
Revenue Next Year
$6.16
N/A
P/E Ratio
★ $22.39
$57.98
Revenue Growth
N/A
N/A
52 Week Low
$102.72
$73.08
52 Week High
$146.84
$160.81

Technical Indicators

Market Signals
Indicator
BOKF
PTGX
Relative Strength Index (RSI) 34.15 43.58
Support Level $123.16 $133.61
Resistance Level $137.22 $142.20
Average True Range (ATR) 2.10 5.17
MACD -0.09 -0.19
Stochastic Oscillator 26.81 14.43

Price Performance

Historical Comparison
BOKF
PTGX

About BOKF BOK Financial Corporation

BOK Financial Corp is a financial institution based in Oklahoma that offers a broad range of nationally competitive financial products and services. The company operates through three main segments: Commercial Banking, Consumer Banking, and Wealth Management. Commercial Banking provides lending, treasury and cash management, and risk management services, and includes the TransFund EFT network. Consumer Banking focuses on retail lending, deposit services, and mortgage loan origination and servicing. Wealth Management engages mainly in brokerage and trading activities, particularly in U.S. government agency mortgage-backed securities and related derivatives. The company generates the majority of its revenue from the Commercial Banking segment.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: